The endocannabinoid system and its relevance for nutrition.
暂无分享,去创建一个
E. Dainese | M. Maccarrone | H. Hansen | L. Avigliano | M. Catani | V. Gasperi | T. Diep
[1] M. Maccarrone. Endocannabinoids: friends and foes of reproduction. , 2009, Progress in lipid research.
[2] H. Hansen,et al. N-acylethanolamines, anandamide and food intake. , 2009, Biochemical pharmacology.
[3] N. Stella,et al. The therapeutic potential of novel cannabinoid receptors. , 2009, Pharmacology & therapeutics.
[4] D. Kendall,et al. Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) , 2009, PPAR research.
[5] M. Kwiatkowska,et al. The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew) , 2009, Physiology & Behavior.
[6] J. M. Mancilla-Díaz,et al. Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats , 2009, Physiology & Behavior.
[7] R. Ross. The enigmatic pharmacology of GPR55. , 2009, Trends in pharmacological sciences.
[8] U. Kristiansen,et al. Ketogenic diet is antiepileptogenic in pentylenetetrazole kindled mice and decrease levels of N-acylethanolamines in hippocampus , 2009, Neurochemistry International.
[9] B. Oldfield,et al. The Effects of Rimonabant on Brown Adipose Tissue in Rat: Implications for Energy Expenditure , 2009, Obesity.
[10] V. Di Marzo,et al. An introduction to the endocannabinoid system: from the early to the latest concepts. , 2009, Best practice & research. Clinical endocrinology & metabolism.
[11] P. Pacher,et al. Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation , 2008, Biochemical and biophysical research communications.
[12] J. McCarron,et al. IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. , 2008, Journal of molecular and cellular cardiology.
[13] Benjamin F. Cravatt,et al. Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects , 2008, Nature chemical biology.
[14] N. DiPatrizio,et al. Inhibiting parabrachial fatty acid amide hydrolase activity selectively increases the intake of palatable food via cannabinoid CB1 receptors. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[15] S. Gaetani,et al. The lipid messenger OEA links dietary fat intake to satiety. , 2008, Cell metabolism.
[16] G. Godlewski,et al. Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations. , 2008, Hypertension.
[17] E. Herradón,et al. Vasorelaxation caused by cannabinoids: mechanisms in different vascular beds. , 2008, Current vascular pharmacology.
[18] N. DiPatrizio,et al. Activating Parabrachial Cannabinoid CB1 Receptors Selectively Stimulates Feeding of Palatable Foods in Rats , 2008, The Journal of Neuroscience.
[19] R. Krauss,et al. Overactive endocannabinoid signaling impairs apolipoprotein E-mediated clearance of triglyceride-rich lipoproteins , 2008, Proceedings of the National Academy of Sciences.
[20] M. Thevis,et al. Δ6‐Desaturase (FADS2) deficiency unveils the role of ω3‐ and ω6‐polyunsaturated fatty acids , 2008, The EMBO journal.
[21] S. Yazulla. Endocannabinoids in the retina: From marijuana to neuroprotection , 2008, Progress in Retinal and Eye Research.
[22] N. Volkow,et al. Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions , 2008, Synapse.
[23] S. Stefano,et al. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. , 2008, European journal of cancer care.
[24] István Katona,et al. Endocannabinoid signaling as a synaptic circuit breaker in neurological disease , 2008, Nature Medicine.
[25] R. Pratley,et al. The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. , 2008, Biochemical and biophysical research communications.
[26] D. Piomelli,et al. Targeted enhancement of oleoylethanolamide production in proximal small intestine induces across-meal satiety in rats. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[27] Peter Tontonoz,et al. Integration of metabolism and inflammation by lipid-activated nuclear receptors , 2008, Nature.
[28] K. Mackie,et al. Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. , 2008, American journal of physiology. Gastrointestinal and liver physiology.
[29] J. Jelsing,et al. Identification of cannabinoid type 1 receptor expressing cocaine amphetamine-regulated transcript neurons in the rat hypothalamus and brainstem using in situ hybridization and immunohistochemistry , 2008, Neuroscience.
[30] V. Marzo. The endocannabinoid system in obesity and type 2 diabetes , 2008, Diabetologia.
[31] U. Pagotto,et al. The Endocannabinoid System and Energy Metabolism , 2008, Journal of neuroendocrinology.
[32] R. Vettor,et al. Endocannabinoids, Adipose Tissue and Lipid Metabolism , 2008, Journal of neuroendocrinology.
[33] D. Diz,et al. Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca2+-induced relaxation of rat mesenteric arteries. , 2008, American journal of physiology. Heart and circulatory physiology.
[34] H. Hansen,et al. Endocannabinoids and Nutrition , 2008, Journal of neuroendocrinology.
[35] Ethan B. Russo. Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions? , 2008, Neuro endocrinology letters.
[36] Christian Skonberg,et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. , 2008, Biochimica et biophysica acta.
[37] F. Mach,et al. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. , 2008, American journal of physiology. Heart and circulatory physiology.
[38] F. Bermúdez-Silva,et al. Presence of functional cannabinoid receptors in human endocrine pancreas , 2008, Diabetologia.
[39] D. Centonze,et al. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum , 2008, Nature Neuroscience.
[40] H. Wyatt,et al. Dietary Fat Increases Energy Intake Across the Range of Typical Consumption in the United States , 2008, Obesity.
[41] K. Mackie,et al. CB2 cannabinoid receptor agonists attenuate TNF‐α‐induced human vascular smooth muscle cell proliferation and migration , 2008, British journal of pharmacology.
[42] P. Bernante,et al. The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. , 2007, The Journal of clinical endocrinology and metabolism.
[43] C. Paraskeva,et al. The cannabinoid δ9‐tetrahydrocannabinol inhibits RAS‐MAPK and PI3K‐AKT survival signalling and induces BAD‐mediated apoptosis in colorectal cancer cells , 2007 .
[44] V. Ralevic,et al. Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed , 2007, British journal of pharmacology.
[45] M. Randall. Endocannabinoids and the haematological system , 2007, British journal of pharmacology.
[46] Z. Song,et al. Molecular and cellular changes induced by the activation of CB2 cannabinoid receptors in trabecular meshwork cells. , 2007, Molecular vision.
[47] L. Parsons,et al. Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration , 2007, The Journal of Neuroscience.
[48] G. Wittert,et al. Effects of cannabinoid receptors on skeletal muscle oxidative pathways , 2007, Molecular and Cellular Endocrinology.
[49] E. Kossoff,et al. The Ketogenic Diet: One Decade Later , 2007, Pediatrics.
[50] V. Marzo,et al. Endocannabinoids and the control of energy balance , 2007, Trends in Endocrinology & Metabolism.
[51] A. Zinsmeister,et al. Effect of a cannabinoid agonist on gastrointestinal transit and postprandial satiation in healthy human subjects: a randomized, placebo‐controlled study , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.
[52] M. Maj,et al. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. , 2006, The Journal of clinical endocrinology and metabolism.
[53] S. Di,et al. Opposing Crosstalk between Leptin and Glucocorticoids Rapidly Modulates Synaptic Excitation via Endocannabinoid Release , 2006, The Journal of Neuroscience.
[54] S. Dey,et al. Jekyll and Hyde : Two Faces of Cannabinoid Signaling in Male and Female Fertility , 2006 .
[55] E. Berry,et al. Endocannabinoids, feeding and suckling – from our perspective , 2006, International Journal of Obesity.
[56] C. Reynet,et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. , 2006, Cell metabolism.
[57] F. Bermúdez-Silva,et al. Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic β-cell , 2006 .
[58] A. Finazzi-Agro’,et al. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells , 2005, Thrombosis and Haemostasis.
[59] Arya M. Sharma,et al. Activation of the peripheral endocannabinoid system in human obesity. , 2005, Diabetes.
[60] M. Palkovits,et al. Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide , 2005, Neuroendocrinology.
[61] P. Casellas,et al. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation. , 2005, European journal of pharmacology.
[62] D. Hardie,et al. Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase* , 2005, Journal of Biological Chemistry.
[63] A. Gerber,et al. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH) , 2005, International Journal of Obesity.
[64] K. Mackie,et al. Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. , 2005, The Journal of clinical investigation.
[65] T. Klein. Cannabinoid-based drugs as anti-inflammatory therapeutics , 2005, Nature Reviews Immunology.
[66] M. Korbonits,et al. The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin , 2004, British journal of pharmacology.
[67] K. Chapman. Occurrence, metabolism, and prospective functions of N-acylethanolamines in plants. , 2004, Progress in lipid research.
[68] B. Cravatt,et al. The endogenous cannabinoid system protects against colonic inflammation. , 2004, The Journal of clinical investigation.
[69] P. Soubrié,et al. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity , 2004, International Journal of Obesity.
[70] N. Ueda,et al. Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners* , 2004, Journal of Biological Chemistry.
[71] Gareth Williams,et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain , 2003, The Journal of cell biology.
[72] E. Berry,et al. Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain , 2003, Brain Research.
[73] P. Hornby,et al. Cannabinoid1 Receptor in the Dorsal Vagal Complex Modulates Lower Oesophageal Sphincter Relaxation in Ferrets , 2003, The Journal of physiology.
[74] T. Hamazaki,et al. n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.
[75] A. Finazzi-Agro’,et al. Leptin Activates the Anandamide Hydrolase Promoter in Human T Lymphocytes through STAT3* , 2003, The Journal of Biological Chemistry.
[76] T. Freund,et al. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. , 2002, Chemistry and physics of lipids.
[77] A. Finazzi-Agro’,et al. Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells. , 2002, The Biochemical journal.
[78] K. Mackie,et al. Localisation of cannabinoid CB1 receptor immunoreactivity in the guinea pig and rat myenteric plexus , 2002, The Journal of comparative neurology.
[79] N. Jamshidi,et al. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.
[80] A. Nilsson,et al. Sources of eicosanoid precursor fatty acid pools in tissues. , 2001, Journal of lipid research.
[81] H. Kilbinger,et al. Differential effects of anandamide on acetylcholine release in the guinea‐pig ileum mediated via vanilloid and non‐CB1 cannabinoid receptors , 2001, British journal of pharmacology.
[82] R. Pertwee. Cannabinoids and the gastrointestinal tract , 2001, Gut.
[83] T. Bisogno,et al. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[84] R. Palmiter,et al. Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.
[85] S. Vandevoorde,et al. Anticonvulsant Activity of N‐Palmitoylethanolamide, a Putative Endocannabinoid, in Mice , 2001, Epilepsia.
[86] K. Michaelsen,et al. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. , 2001, Progress in lipid research.
[87] J. Koch. Δ9-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets , 2001, Pharmacology Biochemistry and Behavior.
[88] A. Finazzi-Agro’,et al. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. , 2001, European journal of biochemistry.
[89] G. Melino,et al. Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors , 2000, The Journal of Biological Chemistry.
[90] L. Petrocellis,et al. Trick or treat from food endocannabinoids? , 1998, Nature.
[91] G. Kunos,et al. Cardiovascular actions of cannabinoids and their generation during shock , 1998, Journal of Molecular Medicine.
[92] H. Hansen. The essential nature of linoleic acid in mammals , 1986 .
[93] R. García,et al. Inhibition of histamine-stimulated gastric acid secretion by Δ9-tetrahydrocannabinol in rat isolated stomach , 1980 .
[94] Masahiko Watanabe,et al. Endocannabinoid-mediated control of synaptic transmission. , 2009, Physiological reviews.
[95] A. Makriyannis,et al. Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? , 2009, Trends in pharmacological sciences.
[96] M. Maccarrone. 16 The Endocannabinoid System and its Manifold Central Actions , 2009 .
[97] F. Fezza,et al. Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system. , 2008, Sub-cellular biochemistry.
[98] I. Matias,et al. Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. , 2008, Biochimica et biophysica acta.
[99] D. Diz,et al. Cytochrome P-450 metabolites of 2-arachidonoylglycerol play a role in Ca 2-induced relaxation of rat mesenteric arteries , 2008 .
[100] A. C. Williams,et al. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. , 2007, International journal of cancer.
[101] F. Fezza,et al. Endocannabinoids in adipocytes during differentiation and their role in glucose uptake , 2006, Cellular and Molecular Life Sciences.
[102] F. Massa,et al. Endocannabinoids and the gastrointestinal tract. , 2006, Journal of endocrinological investigation.
[103] T. Bisogno,et al. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. , 2005, Molecular human reproduction.
[104] P. Pacher,et al. Cardiovascular pharmacology of cannabinoids. , 2005, Handbook of experimental pharmacology.
[105] G. Cabral,et al. Effects on the immune system. , 2005, Handbook of experimental pharmacology.
[106] A. Sanyal,et al. Systemic and portal hemodynamic effects of anandamide. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[107] J. Koch. Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets. , 2001, Pharmacology, biochemistry, and behavior.
[108] R. García,et al. Inhibition of histamine-stimulated gastric acid secretion by delta 9-tetrahydrocannabinol in rat isolated stomach. , 1980, European journal of pharmacology.
[109] K. Mackie,et al. Identification functional characterization of brainstem cannabinoid CB2 receptors. , 2022 .
[110] A. Izzo,et al. Introduction Cannabinoids and Gastrointestinal Motility: Animal and Human Studies Cannabinoid Receptors in the Digestive Tract: Focus on the Myenteric Pplexus Animal Studies on Gastrointestinal Motility , 2022 .